We are live on !
Find out more
Aperio Group Portfolio holdings
AUM
$33.8B
Turnover
6.32%
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$264M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$52.4M |
| 2 |
Tesla
TSLA
|
+$42.1M |
| 3 |
Microsoft
MSFT
|
+$16.9M |
| 4 |
Walt Disney
DIS
|
+$14.5M |
| 5 |
Morgan Stanley
MS
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever NV New York Registry Shares
UN
|
+$48.8M |
| 2 |
AT&T
T
|
+$25.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$20M |
| 4 |
Amazon
AMZN
|
+$15.7M |
| 5 |
Biogen
BIIB
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.35% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1551
Q2 Holdings
QTWO
$4.32B
| $1.09M | ﹤0.01% |
8,616
+590
| +7% | +$63.5K |
2018 Q1
11 quarters
|
|
1552
Tanger
SKT
$4.15B
| $1.09M | ﹤0.01% |
109,217
-7,730
| -7% | -$65.3K |
2014 Q1
27 quarters
|
|
1553
DELISTED
Heritage Commerce
HTBK
| $1.09M | ﹤0.01% |
122,544
+23,689
| +24% | +$192K |
2018 Q4
8 quarters
|
|
1554
Integra LifeSciences
IART
$958M
| $1.08M | ﹤0.01% |
16,655
-63
| -0.4% | -$3.39K |
2014 Q4
24 quarters
|
|
1555
Hyster-Yale Materials Handling
HY
$524M
| $1.08M | ﹤0.01% |
18,107
+1,852
| +11% | +$93.5K |
2017 Q2
14 quarters
|
|
1556
Aaon
AAON
$5.74B
| $1.08M | ﹤0.01% |
24,215
+344
| +1% | +$14.5K |
2014 Q4
24 quarters
|
|
1557
Natera
NTRA
$57.9B
| $1.08M | ﹤0.01% |
10,814
+2,729
| +34% | +$228K |
2020 Q1
3 quarters
|
|
1558
NMI Holdings
NMIH
$3.12B
| $1.07M | ﹤0.01% |
47,348
+2,035
| +4% | +$46.4K |
2017 Q4
12 quarters
|
|
1559
Plexus
PLXS
$5.88B
| $1.07M | ﹤0.01% |
13,707
+647
| +5% | +$48.3K |
2016 Q1
19 quarters
|
|
1560
Marten Transport
MRTN
$1B
| $1.07M | ﹤0.01% |
62,139
+104
| +0.2% | +$1.78K |
2016 Q1
19 quarters
|
|
1561
DELISTED
Barnes Group Inc.
B
| $1.07M | ﹤0.01% |
21,134
+228
| +1% | +$10.1K |
2014 Q1
27 quarters
|
|
|
AERI
1562
DELISTED
Aerie Pharmaceuticals
AERI
| $1.07M | ﹤0.01% |
79,106
+9,978
| +14% | +$121K |
2017 Q1
15 quarters
|
|
1563
Rayonier
RYN
$5.57B
| $1.06M | ﹤0.01% |
39,949
-7,230
| -15% | -$184K |
2014 Q1
27 quarters
|
|
1564
Unifirst Corp
UNF
$5.05B
| $1.06M | ﹤0.01% |
5,029
-369
| -7% | -$70.2K |
2014 Q4
24 quarters
|
|
1565
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.06M | ﹤0.01% |
17,167
-1,496
| -8% | -$85.6K |
2019 Q2
6 quarters
|
|
1566
Enviri
NVRI
$540M
| $1.06M | ﹤0.01% |
58,743
+168
| +0.3% | +$2.7K |
2015 Q4
20 quarters
|
|
1567
Accendra Health
ACH
$16.2M
| $1.06M | ﹤0.01% |
38,988
+4,395
| +13% | +$113K |
2013 Q4
28 quarters
|
|
1568
DELISTED
Flushing Financial
FFIC
| $1.05M | ﹤0.01% |
63,083
-1,084
| -2% | -$15K |
2017 Q1
15 quarters
|
|
1569
iShares MSCI EAFE ETF
EFA
$76.6B
| $1.05M | ﹤0.01% |
+14,368
| New | +$983K |
2020 Q4
0 quarters
|
|
1570
Hecla Mining
HL
$9.48B
| $1.04M | ﹤0.01% |
160,828
-11,362
| -7% | -$60.5K |
2014 Q1
27 quarters
|
|
1571
DELISTED
Encore Wire Corp
WIRE
| $1.04M | ﹤0.01% |
17,126
+2,476
| +17% | +$128K |
2016 Q1
19 quarters
|
|
|
ARGO
1572
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.04M | ﹤0.01% |
23,733
+102
| +0.4% | +$4.07K |
2016 Q2
18 quarters
|
|
1573
DELISTED
ModivCare
MODV
| $1.03M | ﹤0.01% |
7,450
+1,103
| +17% | +$137K |
2017 Q2
14 quarters
|
|
|
RETA
1574
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.02M | ﹤0.01% |
8,287
+2,324
| +39% | +$305K |
2019 Q4
4 quarters
|
|
1575
Upwork
UPWK
$1.17B
| $1.02M | ﹤0.01% |
29,612
+5,103
| +21% | +$146K |
2020 Q1
3 quarters
|
|
Similar funds
LCM
Aperio Group's Q4 2020 Portfolio in Review
As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
- Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
- Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
- Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
- Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
- Aperio Group opened 104 new positions and closed 53 in Q4 2020.
- Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.